Radar › Companies › Genomics · Rockville
Radar · Genomics in Rockville

Best Genomics Companies in Rockville, United States

The 30 best Genomics companies in Rockville, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: OpGen.

30companies tracked
$232Mdisclosed funding
0unicorns
15have raised
FLIAR INTELLIGENCE · GENOMICS × ROCKVILLE

Our analysis of 50 Genomics companies

$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

50companies analysed
84%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2016median founding year

Ranked: Best Genomics companies in Rockville

#CompanyDisclosed fundingLast roundEmployeesFounderStageTech stackPatents & IP focusRecent signals
1OpGen
Developer of diagnostics and bioinformatics platforms for providers
$78M68 mo ago100—PublicWordPressMySQLPHP+16110 patents
Microbial genomic analysis for antibiotic resistance detection and susceptibility testing
—
2OriGene
Provider and manufacturer of proteins, antibodies, and other molecular tools for research applications
$70M137 mo ago141
141 → 130 (-8%)
—Series DCart FunctionalityMagentoMySQL+3414 patents
Protein array platforms for biomarker detection, antibody specificity, and disease diagnostics
—
3Synthetic Biologics
Developing oncolytic virus therapies to overcome solid tumor barriers
$31M51 mo ago21—Late Stage—208 patents
Microbiome-protective enzyme therapeutics and engineered microbial production platforms
—
4Innovative Biosensors
Developer of self-contained biosensor system for rapid diagnostic tests
$20M176 mo ago1—Series B———
5Vigene Biosciences
Developer of life science research reagents for drug discovery and functional genomics
$10M79 mo ago45Zairen Sun
CEO
Acquired———
6CosmosID
Developer of next-generation sequencing (NGS) technologies for the detection of microorganisms
$7M89 mo ago7—Series BWordPressMySQLPHP+2333 patents
Microbial genome identification and quantification using anchor-based bioinformatics data structures.
—
7BioMarker Strategies
Develops Cancer Diagnostics System
$7M110 mo ago8Jerry Parrott
President
Series A—42 patents
Predictive biomarkers and methods to overcome resistance in cancer immunotherapy.
—
8Creatv Bio
Developer of blood based tests for treating cancer
$4M86 mo ago9—Funding Raised———
9Silvec
Developer of RNA-based genetic breeding solutions for plants
$2M17 mo ago26
26 → 13 (-50%)
Anne Simon
Co-Founder
Funding Raised———
10Polaris Genomics
Developer genomic-based diagnostics and therapeutics for neurological conditions
$800K15 mo ago10Tshaka Cunningham
Co-Founder
Series A———
11Full Genomes
Consumer facing genome sequencing company
$602K92 mo ago3Paul Conroy
Founder & Director
Public———
12HepC
Developer of antiviral biologic products
$400K——Thomas Bakacs
CEO
Funding Raised———
13Rise Therapeutics
Developer of targeted immunological-based biologics for gastrointestinal (GI) inflammatory disease
$200K18 mo ago10Neil Fanger
Co-Founder
Seed———
14Cellomics Technology
Provider of products and services to genetically engineer mammalian somatic and stem cells
$150K163 mo ago4—SeedCart FunctionalityBootstrapMicrosoft ASP.NET+7116 patents
AI-driven automated microscopy and image analysis for cell counting and fluorescence imaging
—
15Ariadne Diagnostics
Developer of diagnostic tests for oncology and neurodegenerative diseases
$100K160 mo ago5Ilya Mazo
Co-Founder & CEO
Seed———

Top 12 Genomics companies in Rockville

#1
Funding Raised · Rockville, Maryland · founded 2019 · 26 employees
$1.6Mraised
▾

Developer of RNA-based genetic breeding solutions for plants. It offers genetic modification in plants to protect them against diseases. It offers solutions for trees, vines, and bushes.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 799 LinkedIn followers — 2.5% of this cohort's audience
Hiring: 2 hiring posts in 12 mo (public) · hiring: Fungi Research Associate, Formultion and Delivery Scientist
Activity: 1 awards announced in 12 mo
Funding rounds
  • Jun 2025Grant (prize money)$98K
  • Mar 2025Grant (prize money)$256.5K
  • Sep 2023Grant (prize money)$650K
  • May 2022Grant (prize money)$175K
Founders & team
Anne SimonCo-FounderRafael SimonCo-Founder & President
Investors
Maryland Innovation Initiative, America’s Seed Fund, United States Department of Agriculture, Maryland, OSTI, TEDCO
#2
Series A · Rockville, Maryland · founded 2017 · 10 employees
$800Kraised
▾

Developer genomic-based diagnostics and therapeutics for neurological conditions. The company uses a proprietary bioinformatics engine TruNorth Platform for Neuropsychiatric genomic analysis. Also, it develops PTS-ID a genomic test for the diagnosis and treatment of Post-traumatic stress disorder.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 6.1% of this cohort's audience
Activity: 1 product launches · 1 partnerships (incl. Mediterranean Pharma (psychedelic drug development)) announced in 12 mo
Funding rounds
  • Aug 2025Conventional Debt$250K
  • Oct 2023Conventional Debt$1M
  • May 2023Conventional Debt$1M
  • Feb 2021Conventional Debt$100K
Founders & team
Tshaka CunninghamCo-Founder
Investors
Illumina, Sanford Health, PunchUp Ventures, Stony Lonesome Group, TEDCO
#3
Seed · Rockville, Maryland · founded 2016 · 10 employees
$200Kraised
▾

Developer of targeted immunological-based biologics for gastrointestinal (GI) inflammatory disease. It offers oral delivery platform, TriPartite X (TPX) is a novel DNA assembly approach that allows for the creation of recombinant probiotics to escort targeted protein therapies to the intestinal space. Its drug pipeline includes R-2487, an immunobiotic drug that can cause autoimmunity in tissues distal from the intestinal tract; R-3750 which is being developed for the treatment of gastrointestinal (GI) inflammatory disease.

Funding rounds
  • May 2025Grant (prize money)$2.9M
  • Apr 2025Grant (prize money)$2.1M
  • Mar 2025Grant (prize money)$2.1M
  • Mar 2025Grant (prize money)$2.9M
Founders & team
Neil FangerCo-Founder
Investors
TEDCO, HHS
#4
Public · Rockville, Maryland · founded 2002 · 100 employees
$77.5Mraised
▾

Developer of diagnostics and bioinformatics platforms for providers. The company’s lead product is the Acuitas MDRO Gene Test. Other products include the Acuitas Lighthouse MDRO Management System and the Acuitas Resistome Test. The company’s products and services are designed to enable the identification of hospital patients who are infected with multi-drug resistant organisms, or MDROs.

Funding rounds
  • Feb 2021Post IPO$25M
  • Dec 2020Post IPO$10M
  • Jul 2018Post IPO$285.5K
  • Sep 2017Post IPO$110K
Investors
In-Q-Tel, Merck Global Health Innovation Fund, Highland Capital Partners, Versant Ventures, jVen, CHL Medical Partners
Tech stack
AccessibeBootstrapDigicertGoogle AnalyticsGravity FormsJquery
#5
Late Stage · Rockville, Maryland · founded 1986 · 21 employees
$31.4Mraised
▾

Developing oncolytic virus therapies to overcome solid tumor barriers. This clinical-stage immuno-oncology company focuses on developing oncolytic viruses designed to selectively kill tumor cells and overcome the protective barriers surrounding solid tumors. Their developmental therapies aim to enable systemic delivery and enhance current standard-of-care treatments, offering the potential for longer lives for patients with difficult-to-treat cancers. The company's engineered oncolytic viruses offer a powerful approach to treating therapeutically challenging cancers, overcoming the limitations of traditional oncolytic viruses. They are exploring technologies to expand their therapeutic approach and combine their viruses with a variety of cancer therapies. The company seeks to transform the cancer therapy landscape through innovative solutions in the biotechnology and pharmaceutical industries.

Funding rounds
  • Jul 2022Post IPO$3M
  • Sep 2017Post IPO$12M
  • Sep 2013Grant (prize money)$5.6M
  • Nov 2012Post IPO$10.8M
Investors
Business Innovation Network, Third Security, Kinled Holding
Tech stack
Litespeed
#6
Series D · Rockville, Maryland · founded 1996 · 141 employees
$69.6Mraised
▾

OriGene Technologies is focused on developing proteins, antibodies, and other molecular tools to support the academic, pharmaceutical, and biotech companies in their research of gene functions and drug discovery. Its product lines include the large cDNA and shRNA clone collections, about 5k purified human proteins, monoclonal antibodies (TrueMAB), 140k validated human tissues, and protein microarray products. It also provides a range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from the Company's tissue collection.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers — 24.2% of this cohort's audience
Activity: 1 product launches announced in 12 mo
Funding rounds
  • Jun 2015Series D$17.1M
  • Mar 2014Series C$200K
  • Mar 2013Series C$21.3M
  • Sep 2012Series B$15M
Investors
Sibai Venture Capital Management, Uni-President, Morningside, Zero2IPO Ventures, IDG Capital, Qiming Venture Partners
Tech stack
AdrollAlpine.JsAmazon SesAmazon Web ServicesCart FunctionalityCloudflare
#7
Series B · Rockville, Maryland · founded 2003 · 1 employees
$20.4Mraised
▾

Innovative Biosensors is a developer of a self-contained biosensor system for rapid diagnostic tests. It has developed technology that is a genetically engineered biosensor that allows for extremely rapid testing of analytes, providing high levels of sensitivity and specificity. The patented, self-contained biosensor system is capable of generating a sensitive and specific result with minimal amount of reagents in minutes, making it a cost-effective alternative to traditional laboratory testing. The biosensors can be engineered to detect one target or several targets of interest simultaneously and used to perform a wide variety of bioassays. Designed for real-time detection, minimally-skilled personnel can perform tests and analysis at the site of sampling using small, portable, space-saving instrumentation.

Funding rounds
  • Mar 2012Series B$1.5M
  • Mar 2010Series B$3.9M
  • May 2008Series B$9.5M
  • May 2008Conventional Debt$2M
Investors
SVB, Chart Venture Partners, Lightspeed Venture Partners, Clark Enterprises, Harbert Management, Luksic-Gumoproizvod
#8
Acquired · Rockville, Maryland · founded 2012 · 45 employees
$10.5Mraised
▾

Developer of life science research reagents for drug discovery and functional genomics. Its product portfolio includes adeno associated virus (AAV), lentivirus, human cDNA clones, mammalian expression vector, and molecular bioreagents. Its services include Plasmid, Adenoviral, Lentiviral Cloning, AAV packaging Service, TALE Nuclease, and shRNA Cloning service.

Funding rounds
  • Mar 2020Series A$3M
  • May 2019Series A$7.5M
Founders & team
Zairen SunCEO
Investors
Signet Healthcare Partners, Broadoak Capital Partners, CYwP Funds
#9
Series A · Rockville, Maryland · founded 2007 · 8 employees
$7.3Mraised
▾

BioMarker Strategies develops Cancer Diagnostics System. The company has developed SnapPath that is a Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Its PathMAP functional signaling profiles, created using the SnapPath system, provide a new class of biomarker tests that are highly predictive of individual response for targeted treatments of solid tumors.

Funding rounds
  • Sep 2017Grant (prize money)$299.3K
  • Aug 2016Series A$525K
  • Jul 2016Grant (prize money)$2.3M
  • Sep 2015Grant (prize money)$2.3M
Founders & team
Jerry ParrottPresident
Investors
Abell Foundation, National Cancer Institute, NIH SBIR/STTR, HHS, Springboard Enterprises, DeBere Capital Partners
#10
Series B · Rockville, Maryland · founded 2008 · 7 employees
$7.3Mraised
▾

Developer of next-generation sequencing (NGS) technologies for the detection of microorganisms. The company's GENIUS software suite employs CosmosID’s curated genome database and utilizes proprietary algorithms to obtain, bacterial identification at the species, subspecies, and/or strain level. The company claims that the turnaround time is just a few minutes.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers — 12.4% of this cohort's audience
Activity: 4 product launches announced in 12 mo
Funding rounds
  • 2019Series B—
  • Jan 2016Series B$6M
  • Sep 2011Series A$100K
  • Aug 2011Series A$1.2M
Investors
Plug and Play Tech Center, Applied Value Group, Business Innovation Network
Tech stack
Amazon SesAmazon Web ServicesApache Http ServerBold Page BuilderCloudflareCloudflare Bot Management
#11
Funding Raised · Rockville, Maryland · founded 2020 · 9 employees
$4.2Mraised
▾

Creatv has developed liquid cell biopsy-based test for cancer detection. The company has developed CellSieve microfiltration system to isolate the cancer cells from blood by identifying the cancer-associated macrophage-like cell (CAML) biomarker and enable the development of precision medicines.

Funding rounds
  • Sep 2019Grant (prize money)$197K
  • Sep 2018Grant (prize money)$2.4M
  • Sep 2018Grant (prize money)$297.3K
  • Jul 2018Grant (prize money)$625K
Investors
Military Health
#12
Public · Rockville, Maryland · founded 2012 · 3 employees
$602.1Kraised
▾

Full Genomes uses sequencing technology to provide services such as reports on a customer's ancestry, genealogy, and family history, using full sequencing of the Y chromosome as well as other products. Also provides access to an extensive database of next generation sequencing reports. Allows users to purchase kits online and send it back to the lab. Gets results online.

Funding rounds
  • Mar 2019Seed$25K
  • Aug 2018Seed$187.9K
  • May 2016Seed$19.1K
  • Oct 2015Seed—
Founders & team
Paul ConroyFounder & Director
Tech stack
UbuntuBootstrapAmazon Web ServicesNginxCloudflareSlick

Funding & investor landscape

$232Mtotal disclosed funding
15companies funded
96disclosed rounds
0rounds last 90 days
Most active investors
Business Innovation Network5 rounds
HHS4 rounds
TEDCO4 rounds
Broadoak Capital Partners2 rounds
180 Degree Capital1 rounds
Abell Foundation1 rounds
America’s Seed Fund1 rounds
Applied Value Group1 rounds
Avista Capital Partners1 rounds
CHL Medical Partners1 rounds

Notable founders

Anne Simon
Co-Founder · Silvec
Rafael Simon
Co-Founder & President · Silvec
Tshaka Cunningham
Co-Founder · Polaris Genomics
Neil Fanger
Co-Founder · Rise Therapeutics
Zairen Sun
CEO · Vigene Biosciences
Jerry Parrott
President · BioMarker Strategies
Paul Conroy
Founder & Director · Full Genomes
Thomas Bakacs
CEO · HepC
Ilya Mazo
Co-Founder & CEO · Ariadne Diagnostics
Elena Schwartz
Co-Founder & CSO · Ariadne Diagnostics
Prism market signals · United States · country-scoped Prism corpus, 1,273,702 docs

Market landscape — 10 sub-themes by coverage

Share of Genomics coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Genomics companies are there in Rockville, United States?
Radar tracks 30 indexable Genomics companies headquartered in Rockville, United States that meet our profile-completeness bar.
What is the total funding raised by Genomics companies in Rockville, United States?
The Genomics companies in Rockville, United States on this list have raised a combined $232M in disclosed equity funding across 15 funded companies.
Which is the highest-funded Genomics company in Rockville, United States?
OpGen is the highest-funded Genomics company in Rockville, United States, with $77.5M in disclosed equity funding.
How many Genomics companies in Rockville, United States are funded?
15 of the 30 Genomics companies in Rockville, United States on this list have disclosed at least one equity funding round.
How many Genomics unicorns are there in Rockville, United States?
None of the Genomics companies in Rockville, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Rockville, United States Genomics companies?
The most active investors in Rockville, United States Genomics companies on this list include Business Innovation Network, HHS, TEDCO, Broadoak Capital Partners, 180 Degree Capital.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon